Trial · NCT07898293
TEAS for Gastrectomy Recovery
NCT07898293, Not applicable, Recruiting, The Affiliated Hospital of Qingdao University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. TEAS for Gastrectomy Recovery. Trials, record NCT07898293. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898293
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- TEAS for Gastrectomy Recovery
- NCT number
- NCT07898293
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 104 participants, estimated
- Lead sponsor
- The Affiliated Hospital of Qingdao University
- Conditions
- Gastric Cancer (GC), Stomach Neoplasms
- Interventions
- Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation
- First posted
- 2026-10-27
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to First Flatus After Surgery | Measured from the end of surgery up to hospital discharge (expected up to 7 days postoperatively) | Time from the end of surgery to the patient's first self-reported passage of flatus. Patients and their families are instructed to record the exact time (to the nearest minute) immediately upon first flatus using a postoperative recovery diary card. Bedside nurses verify and collect the diary cards three times daily during rounds. Bowel movements induced by glycerin suppository or enema are excluded. |
| Secondary | Area Under the Curve of Movement-Evoked Pain NRS Scores Over 0-72 Hours | 0 to 72 hours postoperatively | Area under the curve (AUC) of Numerical Rating Scale (NRS) scores for movement-evoked pain (MEP) from 0 to 72 hours postoperatively. The NRS ranges from 0 to 10, where 0 = no pain and 10 = worst possible pain. Higher scores mean a worse outcome. Pain is assessed immediately after coughing using standardized instructions ("Please hold your wound with one hand, take a deep breath, and cough forcefully") at 6, 12, 24, 48, and 72 hours after surgery by a blinded assessor. If the patient cannot perform a standard cough, pain during turning in bed is assessed as an alternative, with the reason recorded in the CRF. AUC is calculated using the trapezoidal rule. Pain during turning and ambulation are recorded simultaneously as exploratory analyses. |
| Secondary | Total Rescue Analgesic Consumption in Morphine Equivalent Dose | From PACU admission (T0) until PCIA discontinuation (expected up to 72 hours postoperatively) | Total dose of all rescue analgesic medications administered for breakthrough pain (NRS ≥ 4) from PACU admission (T0) until discontinuation of PCIA and transition to oral analgesia, converted to morphine equivalent dose (mg MEDD) according to standard conversion factors: IV morphine 1 mg = 1 mg MEDD; IV hydromorphone 0.2 mg = 1 mg MEDD; IV tramadol 10 mg = 1 mg MEDD; oral oxycodone 1 mg = 1.5 mg MEDD. The date, time, and dose of each administration are captured concurrently from nursing medication records and the CRF. |
| Secondary | Time to First Bowel Movement | Measured from the end of surgery up to hospital discharge (expected up to 7 days postoperatively) | Time from the end of surgery to the first bowel movement, excluding those induced by glycerin suppository or enema. |
| Secondary | Time to First Tolerance of Liquid Diet | Measured from the end of surgery up to hospital discharge (expected up to 7 days postoperatively) | Time from the end of surgery to first tolerance of a liquid diet, defined as the absence of vomiting or severe abdominal distension within 2 hours after ingestion. |
| Secondary | Time to First Tolerance of Semi-Liquid Diet | Measured from the end of surgery up to hospital discharge (expected up to 7 days postoperatively) | Time from the end of surgery to first tolerance of a semi-liquid diet, defined as the absence of vomiting or severe abdominal distension within 2 hours after ingestion. |
| Secondary | Time to First Tolerance of Solid Diet | Measured from the end of surgery up to hospital discharge (expected up to 7 days postoperatively) | Time from the end of surgery to first tolerance of a solid diet, defined as the absence of vomiting or severe abdominal distension within 2 hours after ingestion. |
| Secondary | Area Under the Curve of Resting Pain NRS Scores Over 0-72 Hours | 0 to 72 hours postoperatively | Area under the curve (AUC) of Numerical Rating Scale (NRS) scores for resting pain from 0 to 72 hours postoperatively. The NRS ranges from 0 to 10, where 0 = no pain and 10 = worst possible pain. Higher scores mean a worse outcome. Assessed by a blinded assessor at 6, 12, 24, 48, and 72 hours after surgery. AUC is calculated using the trapezoidal rule. |
| Secondary | Time to First PCIA Pump Press | Measured from the end of surgery up to 48 hours postoperatively | Time from the end of surgery to the patient's first postoperative patient-controlled intravenous analgesia (PCIA) pump activation. |
| Secondary | Total Number of PCIA Pump Presses Within 48 Hours Postoperatively | 0 to 48 hours postoperatively | Total number of patient-controlled intravenous analgesia (PCIA) pump presses (both effective and ineffective attempts) within the first 48 hours after surgery. |
1 to 10 of 30Source ClinicalTrials.gov
See all 30 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers5
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898293
GET https://conductscience.org/api/trials/v1/NCT07898293/registered?page=2